MMP7 and breast angiosarcoma: Due to pronounced age-related heterogeneity in BA presentations (e.g., variable hepatic fibrosis severity in neonates vs infants), stratified analyses of MMP-7 diagnostic thresholds and performance across age brackets (0–2 weeks, 2–4 weeks, 1–3 months, >3 months) are strongly recommended.